What is the best pharmacologic treatment for sickle cell disease pain crises? (opens new window)

Baker M, Hafner JW.

Źródło‎: Ann Emerg Med 2012;59(6):515-6.

Indeks‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (opens new window)

Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate. (opens new window)

Frei-Jones MJ, Field JJ, DeBaun MR.

Źródło‎: Pediatr Blood Cancer 2009;53(3):401-5.

Indeks‎: PubMed 19422031

DOI‎: 10.1002/pbc.22048

https://www.ncbi.nlm.nih.gov/pubmed/19422031 (opens new window)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (opens new window)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Źródło‎: Thromb Haemost 2007;98(2):392-6.

Indeks‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (opens new window)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (opens new window)

Okomo U, Meremikwu MM.

Źródło‎: Cochrane Database Syst Rev 2012;(6):CD005406.

Indeks‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (opens new window)

Guidelines for the management of the acute painful crisis in sickle cell disease. (opens new window)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Źródło‎: Br J Haematol 2003;120(5):744-52.

Indeks‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (opens new window)

The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome. (opens new window)

Ahmad FA, Macias CG, Allen JY.

Źródło‎: J Pediatr Hematol Oncol 2011;33(6):415-20.

Indeks‎: PubMed 21792036

DOI‎: 10.1097/MPH.0b013e31821ed4ce

https://www.ncbi.nlm.nih.gov/pubmed/21792036 (opens new window)

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (opens new window)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Źródło‎: Hemoglobin 2004;28(2):85-102.

Indeks‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (opens new window)

Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. (opens new window)

Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR.

Źródło‎: Blood 1998;92(9):3082-9.

Indeks‎: PubMed 9787142

https://www.ncbi.nlm.nih.gov/pubmed/9787142 (opens new window)

A short course of prednisone in the management of acute chest syndrome of sickle cell disease. (opens new window)

Kumar R, Qureshi S, Mohanty P, Rao SP, Miller ST.

Źródło‎: J Pediatr Hematol Oncol 2010;32(3):e91-4.

Indeks‎: PubMed 20216237

DOI‎: 10.1097/MPH.0b013e3181c29c52

https://www.ncbi.nlm.nih.gov/pubmed/20216237 (opens new window)

A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. (opens new window)

Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP.

Źródło‎: Haematologica 2013;98(9):1375-82.

Indeks‎: PubMed 23645695

DOI‎: 10.3324/haematol.2013.086637

https://www.ncbi.nlm.nih.gov/pubmed/23645695 (opens new window)

Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. (opens new window)

Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, Brugnara C.

Źródło‎: JAMA 2003;289(9):1136-42.

Indeks‎: PubMed 12622584

https://www.ncbi.nlm.nih.gov/pubmed/12622584 (opens new window)

Predictors of bacteremia in febrile children with sickle cell disease. (opens new window)

West DC, Andrada E, Azari R, Rangaswami AA, Kuppermann N.

Źródło‎: J Pediatr Hematol Oncol 2002;24(4):279-83.

Indeks‎: PubMed 11972096

https://www.ncbi.nlm.nih.gov/pubmed/11972096 (opens new window)